IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets
18 Dezember 2024 - 7:00AM
UK Regulatory
IMCD to acquire the life science business of YCAM in South Korea
and expand its footprint in the beauty and personal care markets
ROTTERDAM, The Netherlands (18 December 2024)
– IMCD N.V. ("IMCD" or "Company"), a global leading
distribution and formulation partner of speciality chemicals and
ingredients, has signed an agreement to acquire the personal care
and pharmaceutical business of YCAM Corporation, a distributor
based in South Korea ("YCAM").
Founded in 2010, YCAM specialises in
distributing speciality ingredients for the cosmetics, personal
care, and pharmaceutical markets. YCAM represents leading global
suppliers and focuses on providing customers with formulatory
advice and specialty ingredients through its technical team and
laboratory support, helping them to stay abreast of market trends.
YCAM is located in Anyang, South Korea, and generated a revenue of
approximately KRW 26 billion (ca. EUR 17 million) in 2023 with
8 employees.
"This acquisition will be an important step in expanding our
footprint in our beauty and personal care market and further
enriches our life science portfolio," remarked Dongjoon Lee,
Managing Director of IMCD South Korea. "We are excited to welcome
such a dedicated and skilled team to IMCD.
"I am convinced that YCAM’s extensive resources and knowledge
can swiftly integrate into IMCD's global business model, enhancing
its commercial and operational strength in South Korea's personal
care and pharmaceuticals industries,” remarked Munkyum Kim, CEO of
YCAM. “My team has been an invaluable asset to the company, and I
believe they will have even more opportunities to develop and
maximise their potential with IMCD."
The closing of the transaction is subject to customary (regulatory)
closing conditions and is expected to take place in the second
quarter of 2025.
Attached, the full press release in PDF format, the main visual and
photo caption.
- IMCD to acquire the life science business of YCAM in South
Korea
- Photo caption - IMCD to acquire the life science business of
YCAM in South Korea
- Press release - IMCD to acquire the life science business of
YCAM in South Korea
IMCD NV (TG:INX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
IMCD NV (TG:INX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
